| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/23/2013 | US8492329 Bioactive peptides and methods of using same |
| 07/23/2013 | US8492106 Identification methods for ergothioneine transporter modulators and therapeutic uses thereof |
| 07/23/2013 | US8492088 Engineering enzymes through genetic selection |
| 07/23/2013 | US8492081 Aldehyde-fixed, dried platelets with covalently attached exogenous active agent and method of making thereof |
| 07/23/2013 | US8491946 Elastase inhibitor |
| 07/23/2013 | US8491915 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
| 07/23/2013 | US8491912 Methods of treating ocular and other diseases with Syn-134R polypeptide |
| 07/23/2013 | US8491910 Vaccine comprising AMB A 1 peptides for use in the treatment of ragweed allergy |
| 07/23/2013 | US8491906 Selective targeting of tumor vasculature using antibody molecules |
| 07/23/2013 | US8491902 Medicament comprising recombinant antibody against chemokine receptor CCR4 |
| 07/23/2013 | US8491900 Antibodies to signal transduction protein TAB2 |
| 07/23/2013 | US8491891 Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such |
| 07/23/2013 | US8491890 Methods and compositions for inhibiting diseases of the central nervous system |
| 07/23/2013 | US8491889 Method for reducing micronutrient competitions |
| 07/23/2013 | US8491888 Highly absorbable coenzyme Q10 composition and method of producing same |
| 07/23/2013 | US8491886 Viruses for the treatment of cellular proliferative disorders |
| 07/23/2013 | US8491882 Methods for reducing the risk of an unsuccessful pregnancy in a subject having an immune system abberation |
| 07/23/2013 | CA2720332C Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
| 07/23/2013 | CA2642943C Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs |
| 07/23/2013 | CA2536415C Crosslinking reagent for treating intervertebral disc disorders |
| 07/23/2013 | CA2514646C Factor viii polypeptide |
| 07/23/2013 | CA2496005C Use of botulinum toxin for the treatment of fine wrinkles and pore size |
| 07/23/2013 | CA2487351C Export and modification of (poly)peptides in the lantibiotic way |
| 07/23/2013 | CA2438886C Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture |
| 07/23/2013 | CA2428114C Apolipoprotein analogues |
| 07/23/2013 | CA2377357C Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/23/2013 | CA2250835C Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 07/18/2013 | WO2013106787A1 Chimeric factor viii polypeptides and uses thereof |
| 07/18/2013 | WO2013106766A2 THERAPEUTIC INDICATIONS OF miR-1291 |
| 07/18/2013 | WO2013106696A1 Romidepsin formulations and uses thereof |
| 07/18/2013 | WO2013106672A1 Methods and compositions for the treatment of neurodegenerative disease |
| 07/18/2013 | WO2013106437A1 Apj receptor compounds |
| 07/18/2013 | WO2013106175A1 Variant activin receptor polypeptides, alone or in combination with chemotherapy, and uses thereof |
| 07/18/2013 | WO2013105665A1 Collagen structure, and method for producing collagen structure |
| 07/18/2013 | WO2013104929A1 Peptides and peptide derivatives based on xenin |
| 07/18/2013 | WO2013104928A1 Peptide and uses thereof |
| 07/18/2013 | WO2013104909A1 Methods of preparing cells and compositions |
| 07/18/2013 | WO2013104861A1 Injectable solution having a ph of 7 and including at least basal insulin, the pi of which is between 5.8 and 8.5, and a substituted co-poly(amino acid) |
| 07/18/2013 | WO2013104798A1 Modulators of immune responses |
| 07/18/2013 | WO2013104745A1 Pharmaceutical composition |
| 07/18/2013 | WO2013104698A1 Scarring reducing wound treatment |
| 07/18/2013 | WO2013104586A1 Methods for preventing, treating or diagnosing disorders |
| 07/18/2013 | WO2013078217A3 Anti-microbial peptides and methods of use thereof |
| 07/18/2013 | WO2013056054A3 Peptide inhibitors of bace1 |
| 07/18/2013 | WO2013042156A3 Peptides having protective effect towards the inflammatory activity of peptide 31-43 of a-gliadin in celiac disease |
| 07/18/2013 | WO2013020074A3 A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin |
| 07/18/2013 | WO2013016278A3 Modulators of antiviral signaling pathways and therapeutic uses thereof |
| 07/18/2013 | WO2012159187A3 Denv-derived peptides and methods for the inhibition of the flavivirus replication |
| 07/18/2013 | WO2012067866A8 Multivalent vaccine for filariasis |
| 07/18/2013 | US20130184629 Skin treatment devices and methods with pre-stressed configurations |
| 07/18/2013 | US20130184336 Pharmaceutical composition for suppressing angiogenesis, and method for screening active material for suppressing angiogenesis |
| 07/18/2013 | US20130184333 Growth factor isoform |
| 07/18/2013 | US20130184225 Romidepsin formulations and uses thereof |
| 07/18/2013 | US20130184224 Methods for inhibiting tumor growth |
| 07/18/2013 | US20130184223 Methods and compositions related to modulating autophagy |
| 07/18/2013 | US20130184221 Kinase Inhibitors And Uses Thereof |
| 07/18/2013 | US20130184220 Treatment of abnormal or excessive scars |
| 07/18/2013 | US20130184217 Targeting micrornas for the treatment of fibrosis |
| 07/18/2013 | US20130184216 Novel albumin-free factor viii formulations |
| 07/18/2013 | US20130184214 Pharmaceutical compositions and methods |
| 07/18/2013 | US20130184213 Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders |
| 07/18/2013 | US20130184211 Inhibiting binding of fgf23 to the binary fgfr-klotho complex for the treatment of hypophosphatemia |
| 07/18/2013 | US20130184209 Protein stabilization formulations |
| 07/18/2013 | US20130184205 Antitumor combinations containing a vegf-inhibiting agent and 5fu or a derivative thereof |
| 07/18/2013 | US20130184202 Peptide Inhibitors and Methods of Use Thereof |
| 07/18/2013 | US20130184200 Immunogenic Polypeptides and Monoclonal Antibodies |
| 07/18/2013 | US20130184199 Insulin receptor induced elastin production |
| 07/18/2013 | US20130184198 Pulmonary Surfactant Formulations |
| 07/18/2013 | US20130183367 Peptides des-[asp1]-[ala1], angiotensin-(1-7) agonist and pharmaceutical compositions for the treatment of diseases |
| 07/18/2013 | US20130183349 Method for controlled release of parathyroid hormone from cross-linked hyaluronic acid hydrogel |
| 07/18/2013 | US20130183339 Methods and compositions involving immunostimulatory oligodeoxynucleotides |
| 07/18/2013 | US20130183333 Induced activation in dendritic cells |
| 07/18/2013 | US20130183326 Methods and compositions for modulating the activity of the interleukin-35 receptor complex |
| 07/18/2013 | US20130183325 Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations |
| 07/18/2013 | US20130183318 Methods and compositions for the inhibition of stat5 in prostate cancer cells |
| 07/18/2013 | US20130183310 Administering anti-placental growth factor antibodies |
| 07/18/2013 | US20130183309 Fragments, Mutants and Chimeric Fusion Proteins of Leptin For Treating Alzheimer's Disease |
| 07/18/2013 | US20130183304 Neuropilin as a biomarker for bevacizumab combination therapies |
| 07/18/2013 | US20130183300 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 07/18/2013 | US20130183298 Methods of Treating Hepatitis With Anti-TNF alpha Antibodies |
| 07/18/2013 | US20130183289 Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (pml) |
| 07/18/2013 | US20130183285 Methods for accelerating the healing of connective tissues injuries and disorders |
| 07/18/2013 | US20130183284 Method for Treating Systemic Bacterial, Fungal and Protozoan Infection |
| 07/18/2013 | US20130183283 Method for Treating Systemic DNA Mutation Disease |
| 07/18/2013 | US20130183281 Methods and compositons for cell-proliferation-related disorders |
| 07/18/2013 | US20130183279 Fibrin Formulations for Wound Healing |
| 07/18/2013 | US20130183277 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 07/18/2013 | US20130183271 Methods and Compositions Concerning Poxviruses and Cancer |
| 07/18/2013 | US20130183269 Hepatitis C Virus Inhibitors |
| 07/18/2013 | US20130183267 Cyclosporin analogues for preventing or treating hepatitis c infection |
| 07/18/2013 | US20130183266 Compounds and methods for the treatment or prevention of flavivirus infections |
| 07/18/2013 | US20130183265 Mia-2 protein |
| 07/18/2013 | US20130183264 Antagonists of IL-6 to raise albumin and/or lower crp |
| 07/18/2013 | US20130183263 Pharmaceutical compositions and methods |
| 07/18/2013 | US20130183241 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 07/18/2013 | CA2860843A1 Methods for preventing, treating or diagnosing disorders |
| 07/17/2013 | EP2615109A1 Localized pegylated modifications of exendin-4 analogs and use thereof |
| 07/17/2013 | EP2615105A1 Human-derived cell-permeable peptide bioactive peptide conjugate, and use thereof |
| 07/17/2013 | EP2614839A2 Method for using BOC/CDO to modulate hedgehog signaling |
| 07/17/2013 | EP2614833A1 Scarring reducing wound treatment |